Covered recipient · General Payments record
GHAZALEH AHMADI JAZI
General Payments · PY2024
$5,582.11
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $5,000.00 | 1 |
| Food and Beverage | $543.16 | 26 |
| Education | $38.95 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $5,000.00 | 1 |
| ABBVIE INC. | $269.82 | 17 |
| ACADIA Pharmaceuticals Inc | $142.27 | 11 |
| Amneal Pharmaceuticals LLC | $88.53 | 4 |
| Kyowa Kirin, Inc. | $61.78 | 3 |
| Azurity Pharmaceuticals, Inc. | $19.71 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $5,582.11 | 37 |
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.82 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184564 | CMS |
| ABBVIE INC. | $4.27 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184566 | CMS |
| ABBVIE INC. | $20.88 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184568 | CMS |
| ABBVIE INC. | $21.37 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184570 | CMS |
| ABBVIE INC. | $20.88 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184572 | CMS |
| ABBVIE INC. | $23.12 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184574 | CMS |
| ABBVIE INC. | $5.71 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184576 | CMS |
| ABBVIE INC. | $4.59 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184578 | CMS |
| ABBVIE INC. | $19.73 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184580 | CMS |
| ABBVIE INC. | $23.39 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184582 | CMS |
| ABBVIE INC. | $27.23 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184584 | CMS |
| ABBVIE INC. | $19.81 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184586 | CMS |
| ABBVIE INC. | $1.13 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184588 | CMS |
| ABBVIE INC. | $25.53 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184590 | CMS |
| ABBVIE INC. | $20.81 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184592 | CMS |
| ABBVIE INC. | $6.63 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184594 | CMS |
| ABBVIE INC. | $3.92 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103184596 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 08/13/2024 | Education | Undisputed | 01/23/2026 | 1147960773 | CMS |
| ACADIA Pharmaceuticals Inc | $103.32 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147960775 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 09/05/2024 | Education | Undisputed | 01/23/2026 | 1147960777 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 09/16/2024 | Education | Undisputed | 01/23/2026 | 1147960779 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 10/07/2024 | Education | Undisputed | 01/23/2026 | 1147960781 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 10/24/2024 | Education | Undisputed | 01/23/2026 | 1147960783 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 11/04/2024 | Education | Undisputed | 01/23/2026 | 1147960785 | CMS |
| ACADIA Pharmaceuticals Inc | $8.35 | 11/25/2024 | Education | Undisputed | 01/23/2026 | 1147960787 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 12/03/2024 | Education | Undisputed | 01/23/2026 | 1147960789 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 12/09/2024 | Education | Undisputed | 01/23/2026 | 1147960791 | CMS |
| ACADIA Pharmaceuticals Inc | $3.40 | 12/17/2024 | Education | Undisputed | 01/23/2026 | 1147960793 | CMS |
| Amneal Pharmaceuticals LLC | $23.86 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178187 | CMS |
| Amneal Pharmaceuticals LLC | $20.88 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178189 | CMS |
| Amneal Pharmaceuticals LLC | $23.37 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178191 | CMS |
| Amneal Pharmaceuticals LLC | $20.42 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178193 | CMS |
| Azurity Pharmaceuticals, Inc. | $19.71 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134002108 | CMS |
| Kyowa Kirin, Inc. | $18.09 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127030537 | CMS |
| Kyowa Kirin, Inc. | $21.70 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127030539 | CMS |
| Kyowa Kirin, Inc. | $21.99 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127030541 | CMS |
| Medtronic, Inc. | $5,000.00 | 10/09/2024 | Grant | Undisputed | 01/23/2026 | 1112071611 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.